# Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-iia-study-of-survaxm-plus-adjuvant-temozolomide-for-newly-diagnosed/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Manmeet S. Ahluwalia,David A. Reardon,Ajay Abad,William T. Curry,Eric T. Wong,Sheila Figel,Laszlo Mechtler,David M. Peereboom,Alan D. Hutson,Henry Withers,Song Liu,Ahmed Belal,Jingxin Qiu,Kathleen Mogensen,Sanam Dharma,Andrew Dhawan,Meaghan Birkemeier,Danielle Casucci,Michael J. Ciesielski,Robert A. Fenstermaker |
| Citations | 159 |
| DOI | 10.1200/jco.22.00996 |
| Fields | Immunology and Microbiology,Medicine,Neuroscience |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.22.00996?role=tab |
| OpenAlex ID | https://openalex.org/W4311673768 |
| PMID | 36521103 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Andrew Dhawan](https://scholariq.org/researchers/andrew-dhawan/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)

## Paper topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Neuroinflammation and Neurodegeneration Mechanisms](https://scholariq.org/topics/neuroinflammation-and-neurodegeneration-mechanisms/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.